Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 3/20 | 0.40 |
| ▸ | MMP12 | P39900 | 3/20 | 0.40 |
| ▸ | MMP13 | P45452 | 3/20 | 0.40 |
| ▸ | F10 | P00742 | 2/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18571476 | 0.88 | MMP8 (0.42) | MMP8MMP12MMP13F10F2 | |
| SCHEMBL18571477 | 0.71 | PRMT6 (0.43) | ALDH1A1HTTKMT2AMEN1 | |
| SCHEMBL18571275 | 0.70 | MMP8 (0.48) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL24425795 | 0.68 | MMP8 (0.43) | MMP8MMP12MMP13F10F2 | |
| SCHEMBL16924228 | 0.68 | MMP8 (0.50) | MMP8MMP12MMP13F10F2 | |
| SCHEMBL2376899 | 0.65 | KMT2A (0.46) | MMP8MMP12MMP13F2ALDH1A1 | |
| SCHEMBL5696730 | 0.64 | KMT2A (0.45) | MMP8MMP12MMP13F2ALDH1A1 | |
| SCHEMBL16937291 | 0.63 | KMT2A (0.43) | MMP8MMP12MMP13F2ALDH1A1 | |
| SCHEMBL18571267 | 0.62 | ALDH1A1 (0.49) | ALDH1A1HTTKMT2AMEN1RAB9A | |
| SCHEMBL8671567 | 0.62 | MMP8 (0.46) | MMP8MMP12MMP13F2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332443-B2 | Derivatives of halo quinabactin | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11332443-B2 | Derivatives of halo quinabactin | HDHD5, HSF1, NQO2 | MMP8 4864/4885MMP12 3922/4885MMP13 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.